Valneva (VALN) stock gained as its chikungunya vaccine receives marketing authorization in the U.K., expanding the single-dose shot's global reach. Read more here.
Hosted on MSN4h
Valneva’s chikungunya vaccine wins UK approvalValneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) ...
At least four cattle herds in Nevada have tested positive for a strain of H5N1 bird flu never before seen in cows, state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback